AI and the Future of Clinical Trials | Featuring Selin Kurnaz, Craig Lipset & Rosa Hart

Massive Bio Co-Founder and CEO Selin Kurnaz, PhD, joins Rosa Hart and Craig Lipset to discuss how artificial intelligence is transforming access, trust, and innovation in clinical trials.